Pentadecapeptide BPC (Oral)
Also known as: Oral BPC-157
Oral BPC-157 refers to stabilized oral preparations of the pentadecapeptide Body Protection Compound-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), most commonly the arginate salt (sometimes acetate or enteric-coated capsules), intended to survive gastric transit and improve absorption versus the unformulated peptide. This entry covers the salt/stabilized formulations specifically; generic BPC-157 capsules without a salt-form claim are classified under the base BPC-157 entry.
Pricing for Pentadecapeptide BPC (Oral)
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No COAs on file for Pentadecapeptide BPC (Oral)
No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.